These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. An endogenous aryl hydrocarbon receptor ligand, ITE, induces regulatory T cells and ameliorates experimental colitis. Abron JD; Singh NP; Mishra MK; Price RL; Nagarkatti M; Nagarkatti PS; Singh UP Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G220-G230. PubMed ID: 29672155 [TBL] [Abstract][Full Text] [Related]
3. Update on the Therapeutic Efficacy of Tregs in IBD: Thumbs up or Thumbs down? Fantini MC; Monteleone G Inflamm Bowel Dis; 2017 Oct; 23(10):1682-1688. PubMed ID: 28906289 [TBL] [Abstract][Full Text] [Related]
4. Apoptosis of regulatory T lymphocytes is increased in chronic inflammatory bowel disease and reversed by anti-TNFα treatment. Veltkamp C; Anstaett M; Wahl K; Möller S; Gangl S; Bachmann O; Hardtke-Wolenski M; Länger F; Stremmel W; Manns MP; Schulze-Osthoff K; Bantel H Gut; 2011 Oct; 60(10):1345-53. PubMed ID: 21459928 [TBL] [Abstract][Full Text] [Related]
5. Human Blood and Mucosal Regulatory T Cells Express Activation Markers and Inhibitory Receptors in Inflammatory Bowel Disease. Lord JD; Shows DM; Chen J; Thirlby RC PLoS One; 2015; 10(8):e0136485. PubMed ID: 26305224 [TBL] [Abstract][Full Text] [Related]
6. Changes in Foxp3-Positive Regulatory T Cell Number in the Intestine of Dogs With Idiopathic Inflammatory Bowel Disease and Intestinal Lymphoma. Maeda S; Ohno K; Fujiwara-Igarashi A; Uchida K; Tsujimoto H Vet Pathol; 2016 Jan; 53(1):102-12. PubMed ID: 26173451 [TBL] [Abstract][Full Text] [Related]
7. Critical role of ROCK2 activity in facilitating mucosal CD4 Yang W; Zhou G; Yu T; Chen L; Yu L; Guo Y; Cong Y; Liu Z J Autoimmun; 2018 May; 89():125-138. PubMed ID: 29269245 [TBL] [Abstract][Full Text] [Related]
8. Tbet Expression in Regulatory T Cells Is Required to Initiate Th1-Mediated Colitis. Di Giovangiulio M; Rizzo A; Franzè E; Caprioli F; Facciotti F; Onali S; Favale A; Stolfi C; Fehling HJ; Monteleone G; Fantini MC Front Immunol; 2019; 10():2158. PubMed ID: 31572375 [TBL] [Abstract][Full Text] [Related]
9. Expression of CCR6 and CXCR6 by Gut-Derived CD4 Godefroy E; Alameddine J; Montassier E; Mathé J; Desfrançois-Noël J; Marec N; Bossard C; Jarry A; Bridonneau C; Le Roy A; Sarrabayrouse G; Kerdreux E; Bourreille A; Sokol H; Jotereau F; Altare F Gastroenterology; 2018 Oct; 155(4):1205-1217. PubMed ID: 29981781 [TBL] [Abstract][Full Text] [Related]
10. Analysis of murine and human Treg subsets in inflammatory bowel disease. Sun X; He S; Lv C; Sun X; Wang J; Zheng W; Wang D Mol Med Rep; 2017 Sep; 16(3):2893-2898. PubMed ID: 28677759 [TBL] [Abstract][Full Text] [Related]
11. Regulatory T-cell therapy for inflammatory bowel disease: more questions than answers. Himmel ME; Yao Y; Orban PC; Steiner TS; Levings MK Immunology; 2012 Jun; 136(2):115-22. PubMed ID: 22348589 [TBL] [Abstract][Full Text] [Related]
12. Tryptophan Metabolism, Regulatory T Cells, and Inflammatory Bowel Disease: A Mini Review. Ding X; Bin P; Wu W; Chang Y; Zhu G Mediators Inflamm; 2020; 2020():9706140. PubMed ID: 32617076 [TBL] [Abstract][Full Text] [Related]
13. Intestinal IFN-γ-producing type 1 regulatory T cells coexpress CCR5 and programmed cell death protein 1 and downregulate IL-10 in the inflamed guts of patients with inflammatory bowel disease. Alfen JS; Larghi P; Facciotti F; Gagliani N; Bosotti R; Paroni M; Maglie S; Gruarin P; Vasco CM; Ranzani V; Frusteri C; Iseppon A; Moro M; Crosti MC; Gatti S; Pagani M; Caprioli F; Abrignani S; Flavell RA; Geginat J J Allergy Clin Immunol; 2018 Nov; 142(5):1537-1547.e8. PubMed ID: 29369775 [TBL] [Abstract][Full Text] [Related]